טוען...

First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN

PURPOSE: Rare cancers are defined by an incidence of <6 out of 100 000 cases per year. They are under-represented in clinical research including tumour molecular analysis. The aim of Arcagen is to generate a multinational database integrating clinical and molecular information of patients with ra...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	ESMO Open
Main Authors:	Morfouace, Marie, Stevovic, Aleksandra, Vinches, Marie, Golfinopoulos, Vassilis, Jin, Dexter X., Holmes, Oliver, Erlich, Rachel, Fayette, Jerome, Croce, Sabrina, Ray-Coquard, Isabelle, Girard, Nicolas, Blay, Jean-Yves
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMJ Publishing Group 2020
נושאים:	Original Research
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7709508/ https://ncbi.nlm.nih.gov/pubmed/33262201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2020-001075
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN

פריטים דומים